These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4213986)

  • 1. Preliminary investigations of Pseudomonas aeruginosa vaccine in patients with leukemia and cystic fibrosis.
    Pennington JE
    J Infect Dis; 1974 Nov; 130 Suppl(0):S159-62. PubMed ID: 4213986
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: Pseudomonas vaccines.
    Lancet; 1975 Jul; 2(7926):168. PubMed ID: 49756
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of a Pseudomonas Aeruginosa vaccine in pateints with acute leukemia and cystic fibrosis.
    Pennington JE; Reynolds HY; Wood RE; Robinson RA; Levine AS
    Am J Med; 1975 May; 58(5):629-36. PubMed ID: 805535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa infection and humoral antibody response of patients with cystic fibrosis.
    Neter E
    J Infect Dis; 1974 Nov; 130 Suppl(0):S132-3. PubMed ID: 4213765
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospective, controlled study of a polyvalent pseudomonas vaccine in cystic fibrosis--three year results.
    Langford DT; Hiller J
    Arch Dis Child; 1984 Dec; 59(12):1131-4. PubMed ID: 6441523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccinations against Pseudomonas aeruginosa: active and passive alternatives.
    Bellanti JA; Zeligs BJ; Kulczycki LL
    Pediatr Pulmonol Suppl; 1997; 16():269-70. PubMed ID: 9443307
    [No Abstract]   [Full Text] [Related]  

  • 7. Microbiological background for anti-Pseudomonas aeruginosa vaccination in cystic fibrosis.
    Bauernfeind A; Przyklenk B
    Behring Inst Mitt; 1997 Feb; (98):256-61. PubMed ID: 9382748
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccines for preventing infection with Pseudomonas aeruginosa in people with cystic fibrosis.
    Keogan MT; Johansen HK
    Cochrane Database Syst Rev; 2000; (2):CD001399. PubMed ID: 10796780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic Pseudomonas aeruginosa airway colonization in cystic fibrosis patients : Prevention concepts].
    Dittrich AM
    Internist (Berl); 2017 Nov; 58(11):1133-1141. PubMed ID: 28963697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter vaccine trial using the Pseudomonas aeruginosa flagella vaccine IMMUNO in patients with cystic fibrosis.
    Döring G; Dorner F
    Behring Inst Mitt; 1997 Feb; (98):338-44. PubMed ID: 9382758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinity constants of naturally acquired and vaccine-induced anti-Pseudomonas aeruginosa antibodies in healthy adults and cystic fibrosis patients.
    Bruderer U; Cryz SJ; Schaad UB; Deusinger M; Que JU; Lang AB
    J Infect Dis; 1992 Aug; 166(2):344-9. PubMed ID: 1634805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Döring G
    Int J Med Microbiol; 2010 Dec; 300(8):573-7. PubMed ID: 20940108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled prospective trial of Pseudomonas aeruginosa vaccine in children with acute leukemia.
    Haghbin M; Armstrong D; Murphy ML
    Cancer; 1973 Oct; 32(4):761-6. PubMed ID: 4201654
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-idiotype vaccines for immunity to bacterial polysaccharides: induction of functional antibodies to polysaccharide antigens of Pseudomonas aeruginosa.
    Schreiber JR
    Springer Semin Immunopathol; 1993; 15(2-3):235-46. PubMed ID: 7504840
    [No Abstract]   [Full Text] [Related]  

  • 15. An ELISA to detect antipseudomonal IgA antibodies in sera of patients with cystic fibrosis.
    Brett MM; Ghoneim AT; Littlewood JM
    J Clin Pathol; 1988 Oct; 41(10):1130-4. PubMed ID: 3142934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis.
    Johansen HK; Gøtzsche PC
    Cochrane Database Syst Rev; 2008 Oct; (4):CD001399. PubMed ID: 18843616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis.
    Schaad UB; Lang AB; Wedgwood J; Ruedeberg A; Que JU; Fürer E; Cryz SJ
    Lancet; 1991 Nov; 338(8777):1236-7. PubMed ID: 1682645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of naturally occurring antibodies to mucoid Pseudomonas aeruginosa in cystic fibrosis patients.
    Pier GB
    J Infect Dis; 1996 Feb; 173(2):513-5. PubMed ID: 8568328
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunization of noncolonized cystic fibrosis patients against Pseudomonas aeruginosa.
    Cryz SJ; Wedgwood J; Lang AB; Ruedeberg A; Que JU; Fürer E; Schaad UB
    J Infect Dis; 1994 May; 169(5):1159-62. PubMed ID: 8169414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis and therapy of Pseudomonas aeruginosa infection in cystic fibrosis and immunocompromised patients.
    Lang AB; Horn MP; Imboden MA; Zuercher AW
    Vaccine; 2004 Dec; 22 Suppl 1():S44-8. PubMed ID: 15576201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.